Mucin gene (MUC1) transfected dendritic cells as vaccine: Results of a phase I/II clinical trial

Cancer Immunology, Immunotherapy

Volumn 51, Issue 11-12, 2002, Pages 669-673

  Pecher, Gabriele ^a,c,d   Häring, Arnt ^a,c   Kaiser, Lothar ^b   Thiel, Eckhard ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Screening Laboratory Hannover   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Dendritic cell; Gene transfer; Immunotherapy; Mucin (MUC1); Vaccine

Indexed keywords

CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; LIPOSOME; MUCIN 1; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL SECRETION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; FEASIBILITY STUDY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; IMMUNE RESPONSE; MALE; PANCREAS CANCER; PAPILLARY CARCINOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SAFETY; T LYMPHOCYTE;

ADULT; AGED; CA-15-3 ANTIGEN; DENDRITIC CELLS; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; MALE; MIDDLE AGED; NEOPLASMS; TRANSFECTION; VACCINATION;

EID: 0036453668     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-002-0317-z     Document Type: Article

References (23)

1. Aicher A, Westermann J, Cayeux S, Willimsky G, Daemen K, Blankenstein T, Uckert W, Dorken B, Pezzutto A (1997) Successful retroviral mediated transduction of a reporter gene in human dendritic cells: Feasibility of therapy with gene-modified antigen-presenting cells. Exp Hematol 25:39
2. Alijagic S, Moller P, Artuc M, Jurgovski K, Czarnetzki BM, Schadendorf (1995) Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol 25:3100
3. Apostolopoulos V, Karanikas V, Haurum JS, McKenzie IF (1997) Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen. J Immunol 159:5211
4. Banchereau J, Steinman, RM (1998) Dendritic cells and the control of immunity. Nature 392:245
5. Brossart P, Heinrich KS, Stuhler G, Behnke L, Reichardt VL, Stevanovic S, Muhm A, Rammensee HG, Kanz L, Brugger W (1999) Identification of HLA-A2-restricted T -cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. Blood 93:4309
6. Brossart P, Wirths S, Stuhler G, Reichardt VL, Kanz L, Brugger W (2000) Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 96:3102
7. Butterfield LH, Jilani SM, Chakraborty NG, Bui LA, Ribas A, Dissette VB, Lau R, Gamradt SC, Glaspy JA, McBride WH, Mukherji B, Economou JS (1998) Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. J Immunol 161:5607
8. De Bruijn ML, Schuurhuis DH, Vierboom MP, Vermeulen H, de Cock KA, Ooms ME, Ressing ME, Toebes M, Franken KL, Drijfhout JW, Ottenhoff TH, Offringa R, Melief CJ (1998) Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells. Cancer Res 58:724
9. Diebold SS, Kursa M, Wagner E, Cotten M, Zenke M (1999) Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J Biol Chem 274:19087
10. Finn OJ, Jerome KR, Henderson RA, Pecher G, Domenech N, Magarian-Blander J, Barratt-Boyes SM (1995) MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 145:61
11. Henderson RA, Nimgaonkar MT, Watkins SC, Robbins PD, Ball ED, Finn OJ (1996) Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res 56:3763
12. Homma S, Toda G, Gong J, Kufe D, Ohno T (2001) Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice. J Gastroenterol 36:764
13. Jerome KR, Barnd DL, Bendt KM, Boyer CM, Taylor-Papadimitriou J, McKenzie IF, Bast RC Jr, Finn OJ (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51:2908
14. Kaplan JM, Yu Q, Piraino ST, Pennington SE, Shankara S, Woodworth LA, Roberts BL (1999) Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens. J Immunol 163:699
15. Kikuchi T, Akasaki Y, Irie M, Homma S, Abe T, Ohno T (2001) Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother 50:335
16. Magarian-Blander J, Ciborowski P, Hsia S, Watkins SC, Finn-OJ (1998) Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1. J Immunol 160:3111
17. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4:328
18. Nestle FO, Banchereau J, Hart D (2001) Dendritic cells: On the move from bench to bedside. Nat Med 7:761
19. Pecher G, Finn OJ (1996) Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells. Proc Natl Acad Sci USA 93:1699
20. Pecher G, Spahn G, Schirrmann T, Kulbe H, Ziegner M, Schenk JA, Sandig V (2001) Mucin gene (MUC1) transfer into human dendritic cells by cationic liposomes and recombinant adenovirus. Anticancer Res 21:2591
21. Pecher G, Schirrmann T, Kaiser L, Schenk JA (2001) Efficient cryopreservation of dendritic cells transfected with cDNA of a tumour antigen for clinical application. Biotechnol Appl Biochem 34:161
22. Szabolcs P, Gallardo HF, Ciocon DH, Sadelain M, Young JW (1997) Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity. Blood 90:2160
23. Zheng L, Huang XL, Fan Z, Borowski L, Wilson CC, Rinaldo CR Jr (1999) Delivery of liposome-encapsulated HIV type 1 proteins to human dendritic cells for stimulation of HIV type 1-specific memory cytotoxic T lymphocyte responses. AIDS Res Hum Retroviruses 15:1011